Consolidated Statement Of Profit Or Loss

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7315166

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
552,860,000,000 JPY
579,657,000,000 JPY
Cost of sales
160,890,000,000 JPY
242,990,000,000 JPY
Gross profit
391,970,000,000 JPY
336,667,000,000 JPY
Selling, general and administrative expenses
49,901,000,000 JPY
54,280,000,000 JPY
Operating profit (loss)
258,195,000,000 JPY
210,910,000,000 JPY
Finance costs
-4,000,000 JPY
11,000,000 JPY
Profit (loss) before tax
258,690,000,000 JPY
213,656,000,000 JPY
Income tax expense
72,428,000,000 JPY
56,963,000,000 JPY
Profit (loss)
186,262,000,000 JPY
JPY
JPY
186,262,000,000 JPY
JPY
186,262,000,000 JPY
156,693,000,000 JPY
JPY
JPY
156,693,000,000 JPY
156,693,000,000 JPY
JPY
Profit (loss) attributable to
Owners of parent
186,262,000,000 JPY
156,693,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
113.20
95.25
Diluted earnings (loss) per share
113.19
95.23

Talk to a Data Expert

Have a question? We'll get back to you promptly.